SHERMAN OAKS, CA, UNITED STATES, July 6, 2026 /EINPresswire.com/ -- Los Angeles, California Artificial intelligence has ...
Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R 2 ) ...